Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Oct 2.
Published before final editing as: Subst Use Misuse. 2025 Sep 2:1–10. doi: 10.1080/10826084.2025.2555499

Content Analysis of Derived Intoxicating Cannabis Vape Product Attributes and Marketing In an Online Retail Environment

Julia Chen-Sankey 1,2, Cassidy R LoParco 3, Kathryn La Capria 2, Siyan Meng 1, Rosanna Mazzeo 1, Neha Vijayakumar 1, Amanda Y Kong 4, Kayla K Tillett 5, Carla J Berg 3,6, Matthew E Rossheim 5
PMCID: PMC12486249  NIHMSID: NIHMS2108513  PMID: 40898444

Abstract

Introduction.

The 2018 U.S. Farm Bill unintentionally resulted in the proliferation of derived intoxicating cannabis vape products (DICVPs), raising concerns about associated health risks. To inform prevention efforts, this study analyzed the product attributes and marketing features of DICVPs sold online, particularly features that could attract youth or lower risk perception.

Methods.

In 2023, product attributes and descriptions of 490 flavored DICVPs were extracted from two online retail websites. In 2024, two trained coders thematically coded product descriptions for their product marketing features.

Results.

Overall, 95 unique brands and 26 unique intoxicating cannabinoids were identified. The most frequent marketing features overall were vape product design and use (99.0%), including vaping satisfaction, discreetness, convenience, and use instructions. Regulation and compliance messages (91.6%) were also prevalent, including lab testing for additives and/or chemicals, health warnings, hemp-derived labels, references to the Farm Bill, and U.S. Food and Drug Administration approval statements. Other prominent themes included: flavor and sensation claims (79.6%, i.e., flavor variety, fruit flavors); psychoactive effect claims (43.3%, e.g., potency or expected user experience); product quality claims (38.4%, e.g., “quality,” “natural,” “purity”); and other positive effect claims (33.9%, e.g., mood enhancement, relaxation).

Discussion.

The DICVP online marketplace is highly fragmented with a variety of brands and intoxicating compounds. Common marketing strategies promoting appealing flavors and positive vaping experiences may increase their appeal to young people. Features related to product legality and quality may reduce perceived risks and barriers to using products. Continuous monitoring of the DICVP marketplace is needed to inform policymaking.

Keywords: Cannabis marketing, cannabis advertising, derived cannabis vape products, online retailers, cannabis product descriptions

INTRODUCTION

Since the passage of the 2018 Farm Bill (the Agriculture Improvement Act), which excluded hemp (≤0.3% delta-9 tetrahydrocannabinol [THC]) from the U.S.’ list of controlled substances (1), many new types of derived intoxicating cannabis products (DICPs), are being sold widely throughout the U.S. market (e.g., Delta-8 THC, Delta-10 THC) (26). While previous literature has referred to these as “derived psychoactive cannabis products” (2,7,8), the term “DICPs” reflects the current public health and policy focus on intoxicating rather than broadly psychoactive cannabinoids. As a result, researchers are increasingly using the term “DICPs” to distinguish intoxicating cannabinoids (e.g., Delta-8 THC, Delta-9 THC, THC-O, HHC) from non-intoxicating ones (e.g., CBD, CBG). (6,9)

Studies have found that DICPs have proliferated across the country and come in various forms, the most common of which are edibles (e.g., gummies, desserts, beverages) and vape products (e.g., cartridges, pods, or disposables) (25). DICPs are widely sold in gas stations, convenience stores, smoke/vape/head shops, and online, often in ways that are both accessible and attractive to young people (24,8,10). Consistent with concerns regarding youth access and appeal, national data from 2024 shows that one in eight 12th graders (12.3%) reported using Delta-8 THC in the past year (11). This is likely an underestimation of DICP use, considering the dozens of other DICPs beyond Delta-8 THC (24,12).

Similar to traditional cannabis products, DICPs may result in acute health effects, including anxiety, lethargy, and impaired coordination (13). Regular and long-term use of DICPs may lead to cannabis dependence, physical health risks (e.g., motor vehicle collisions), as well as psychosis and other mental health illnesses (13). Use of DICPs also carries risks unique to those of traditional cannabis. DICPs frequently feature misleading or inaccurate labeling and are often not tested for potency or contamination (14,15). Reports indicate some have been tainted with heavy metals, and they have been linked to thousands of incidents of accidental ingestion, some of which required medical attention, especially among young individuals (1618). At the same time, the availability and use of higher potency cannabis products, including DICPs, have been on the rise, which is concerning because high-potency cannabis products and younger age are both primary risk factors for developing cannabis dependence and cannabis-induced psychosis (19). Additionally, DICP use, and cannabis use in general, may negatively impact youths’ developing brains, leading to poor educational outcomes and difficulty transitioning to work and adult roles (20). Therefore, stricter DICP regulations are needed to protect public health.

Derived intoxicating cannabis vape products (DICVPs) are a commonly sold form of DICPs in brick-and-mortar and online stores (25). DICVPs resemble the appearance of traditional nicotine vape products and may be especially attractive to young people due to the highly convenient and discreet nature of product use. In addition, almost all DICVPs sold in the marketplace come in fruit and candy flavors (21), which research indicates is one of the most appealing product attributes for using nicotine vape products among youth and young adults (2224). Evidence shows that the potency of cannabis concentrates inhaled through vaping is substantially higher than for flower cannabis products (25,26), potentially increasing the risk of dependence or negative effects. Cannabis vaping also carries a heightened risk of respiratory harm, including vaping-induced acute respiratory failure (27). Certain intoxicating cannabinoids may be especially harmful when vaped, such as Delta THC-O, which has been shown to produce a potent toxicant when heated in a vape device (28). In addition, vaping has a more rapid onset than other modalities (e.g., edibles, capsules), causing individuals to experience more immediate effects (29). This is because when cannabis is smoked or vaped, THC rapidly enters the bloodstream. In contrast, when THC is ingested through edibles, it is absorbed more slowly due to needing to be digested first, resulting in delayed effects (30).

Research demonstrates that youth exposure, through various industry marketing channels, to cannabis advertising in general and cannabis vape advertising in particular, is associated with cannabis vape product use (3133). However, there is a lack of systematic understanding of the product attributes and marketing strategies used by the industry to promote DICVPs. Investigating product attributes is crucial because these attributes—such as potency, price, and type of intoxicating cannabinoid(s)—are specific product characteristics that can significantly impact perceptions, behavior, and health outcomes (34,35). Examining marketing features, which are used to promote product functionalities and benefits, can shed light on their potential appeal to young people and shape consumers’ expectancies (the anticipated outcomes from using the products) (2224). Marketing features such as flavor and sensation claims, sleek and discreet device design, reduced harm claims, and social and mood enhancement benefits can make DICVPs seem more attractive and healthier to use for young consumers (36). Examining the presence of regulation-related claims may further provide insights into how the industry and consumers may perceive the legality, safety, and risks of using the products. Product attributes and marketing strategies used in online retail are particularly important to examine due to the inadequate age verification practices and the wide availability of DICVP marketing and sales throughout the country (37,38).

To address these research gaps, this exploratory study analyzed content from two highly visited DICP retail websites to identify product attributes and marketing features of DICVPs (2). The attributes and marketing features frequently presented on these sites may offer insight into common online DICP marketing strategies used to enhance product appeal and shape user expectancies. Additionally, this analysis may highlight the product attributes and marketing features that may be particularly attractive to youth (e.g., flavor claims, socialization effects) or convey health-related benefits that could contribute to misuse (e.g., unfounded claims of physical or mental health benefits). These findings will be critical for guiding future research on how specific, high-impact DICVP attributes and marketing features influence product appeal, use intentions, and behaviors. This can potentially inform marketing restrictions on certain DICVP attributes and features to reduce product misuse.

METHODS

Data Source and Measures

In May 2023, the search term “buy delta thc” was entered in Google’s search engine in Incognito mode to generate results of online vendors unbiased by search history. The first 100 results were documented to provide an accurate snapshot of the product landscape.

The three cannabis retailers that sold DICPs with the highest web traffic, as determined by Similarweb, were selected to review. Of the three websites, two that were third-party vendors selling multiple brands with diverse offerings, were included in the current study: Element Vape (elementvape.com) and Premium Delta-8 and CBD (delta8resellers.com). The third website, excluded from this analysis, was a single-brand manufacturer site and, therefore, did not align with the study’s aim of capturing market variety across DICP brands. In April 2023, the two websites chosen for the current study had a high volume of web traffic, with 2.1 million visits to Element Vape and 547,500 visits to Premium Delta-8 and CBD (2). Element Vape, based out of California, offers a variety of cannabis and hemp-derived cannabis products and accessories. Premium Delta-8 and CBD, based out of New Jersey, specializes in various modalities of hemp-derived cannabis products, as well as “alternative wellness products” (e.g., topicals, CBD products). Details about this website search process can be found in our previous study (2).

Product attributes and descriptions of all DICVPs listed on the websites were recorded during the one-time data collection period. Product attributes refer to specific characteristics that define a product. In the current study, product attributes of each DICVP (n=490) were recorded, including brand name, vape product modality (cartridge-based/reusable or disposable), pack size, price, and the type(s) of intoxicating cannabinoid(s), such as Delta-8 THC. Product descriptions were also recorded, i.e., the written content accompanying each DICVP product, which detailed various marketing features of the products. Marketing features are defined as claims or descriptors used to highlight product functionalities and benefits that make a product desirable to consumers. Products from the same website were de-duplicated if their only difference was in flavors, quantity, or the presence or absence of a battery. Institutional Review Board approval was not required because this study utilized publicly available data and was not considered human subject research under 45 CFR 46.102(d).

Coding Procedure for Product Marketing Features

In June-August 2024, the research team conducted a content analysis of the recorded product descriptions to capture marketing features of all DICVPs from the two websites. Both deductive and inductive approaches were used to generate “codes” that each represent distinct product marketing features, categorized under broader thematic categories. The deductive approach involved leveraging existing research on cannabis product marketing features and empirical evidence of outcome expectancies for using cannabis and vape products (15,40,41). The inductive approach involved conducting a qualitative review of a sample of the product descriptions to develop and generate additional codes. The codes from the following categories were generated from the deductive process: flavor and sensation, psychoactive effects, and other positive effects. Codes from the remaining categories (vape product design and use, regulation and compliance, and product quality) were generated from the inductive process. Codes were not mutually exclusive.

All DICVPs examined in the study either carry explicit flavor labels (e.g., strawberry, cookies and cream, green apple) or cannabis-strain names that imply specific tastes (e.g., Wedding Cake, Sour Diesel, Northern Lights). Cannabis strains are distinct genetic varieties of the cannabis plant, each bred to produce a characteristic mix of cannabinoids and terpenes. Those chemical profiles give every strain its signature aroma, flavor, potency, and perceived effects (e.g., energizing, relaxing, or balanced). Although some cannabis strains have “non-flavor” flavor names (8) – defined as a flavor name that does not reflect traditional taste expectations (e.g., white widow, jet fuel, green crack, blue dream) – they still have distinct smells and tastes that are derived from the natural flavor profile of the plant or added terpenes. In contrast, non-strain flavored products rely on artificial flavoring agents (e.g., strawberry, cookies and cream, green apple). Because many strain names also evoke conventional tastes (e g., Pineapple Express), distinguishing strain-based from non-strain flavors proved difficult. We therefore treated all flavor references uniformly and developed a codebook to capture any product description related to flavor or sensory profile as a marketing feature.

Three trained coders from the research team first reviewed the codebook and tested the codes by independently coding a sample of the product descriptions for marketing features. The research team then met to discuss and confirm the final codes. Inter-rater reliability was established through two rounds of double coding using a sub-sample (n=50 each round) of product descriptions. Discrepancies were resolved, and the codebook was refined through discussion during team meetings. After the second round of double-coding, an average inter-rater reliability of Krippendorff’s alpha >0.8 across codes was reached (42) (average Krippendorff’s alpha=0.82 across codes). Discrepancies in coding were further discussed to improve reliability. The remaining product descriptions were then randomly split between coders for content coding. The final codebook of marketing features consisted of six thematic categories covering 29 codes (see Table 1 for all marketing feature categories, their specific codes, and definitions).

Table 1.

Frequencies of product marketing feature categories and codes1 of the 490 online derived intoxicating cannabis vape products

Marketing Feature Categories and Codes Definition % n Example
Vape Product Design and Use 99.0 485
Product design Mentions any product design aspects, such as product colors, shapes, or specific features (i.e., heating elements, stainless steel hardware) or type of vape product (cartridge or disposable). 97.6 478 The Disposables are USB-C rechargeable and feature a slim and sleek design.
Vaping satisfaction Mentions the user will experience satisfaction from using the product and may include phrases like “enjoy the experience,” “satisfying experience,” “positive vaping sensation.” 28.2 138 Leave you satisfied after each hit.
Discreetness/convenience Includes claims that the product is convenient, discreet, easy to use, and use on the go. 28.0 137 Its sleek and compact design ensures easy portability, allowing you to enjoy your favorite strains anytime, anywhere.
Use instructions Includes general instructions on how to use the products (e.g., how to power up the product). 12.2 60 To switch the device on or off, simply click the power button 5 times. Activate the pre-heat mode by clicking the power button 2 times, and once the light switches off, press and hold the power button to start vaping.
Regulation and Compliance 91.6 449
Lab tested for additives and chemicals References the product being lab-tested or third-party tested for addictive and chemicals or free of chemicals, bacteria, additives, fillers, or other harmful substances etc. 62.5 306 Tested by third-party labs, the Delta-8 disposables are free of any impurities, pesticides, and toxins.
Health warning Includes the California state warning about using cannabis products. 51.2 251 WARNINGS: Consuming this product can expose you to chemicals including beta-myrcene, which is known to the State of California to cause cancer and Δ9-Tetrahydrocannabinol, which is known to the State of California to cause birth defects or other reproductive harms.
Hemp-derived label Includes claims about the product being hemp-derived or made of hemp. 45.3 222 Made from USA grown hemp.
2018 Farm Bill Includes claims about the product being Farm Bill compliant or federally legal under the Farm Bill. 32.7 160 These cartridges are 2018 farm bill compliant containing less than 0.3% delta-9 THC.
FDA approval statement Includes the statement that the product has not been evaluated or approved by the FDA. 6.3 31 These statements have not been evaluated by the Food and Drug Administration.
Flavor and Sensation 78.6 390
Flavor variety Includes claims that the product comes in a variety of flavor options. 62.9 308 Get ready to unleash the flavor explosion with a variety of mouthwatering options!
Fruit flavor Describes the product to taste like fruit(s) (e.g., citrus flavors, strawberry, watermelon, grape, etc.). 38.2 187 Blackberry: The juicy sweetness of blackberries can now be enjoyed with the uplifting effects of Delta-8 THC!
General flavor description Includes terms used to describe the product’s flavor (big flavor, flavorful, etc.) or general sensations of the product’s flavor (tasty, delicious, refreshing, etc.). 30.2 148 Try our tasty and satisfying Delta-8 Live Resin Disposables for delicious flavors and a powerful pinch of euphoria!
Other flavor Includes the product’s flavor name that is not a fruit or words that describe the product to taste like non-fruit related flavors such as mint, floral, dessert, candy (cake, mint, candy, etc.). 29.4 144 Each hit delivers a savory blast of sweet and creamy vanilla undercut with hints of earthy pepper and bready sourness.
Flavor sensations Includes terms to describe the tastes, smells, and textures that make up the product’s flavor, such as “sweet,” “sour,” and “spicy.” 28.2 138 Dominating the terpene profile is the subtle tartness of fresh berries that give way to a sweet aftertaste that saturates your palate.
Psychoactive Effects 43.3 212
Potency descriptors Includes product potency such as powerful, potent, or strong. 35.3 173 Each disposable device contains 1.8 grams of the most potent distillate available.
Psychoactive effects Includes the psychoactive effects of the product on the user such as feeling high, stoned, or buzzed. 14.7 72 Disposables provides an uplifting and functional buzz like no other.
Psychoactive effect use instructions Includes a statement about how the product should be vaped, the number of puffs that one should be starting with, and the number of minutes for waiting for adjusting for tolerance. 9.0 44 We suggest starting with 1 puff and hold each hit 5–10 seconds and wait 30 mins to test your tolerance.
Product Quality 38.4 188
Natural Includes the word ‘natural.’ 16.5 81 Flavored with all-natural terpenes.
Quality Includes the word ‘quality.’ 12.5 43 The most potent and highest quality distillate available.
Purity Includes the word ‘pure/purity/purified.’ 10.6 52 1 gram of delta-8 cannabinoids harvested from legal hemp plants, tested to ensure potency and purity.
Premium Includes the word ‘premium.’ 10.2 50 The Delta-9 disposable vape pen contains 3 grams of premium hemp-derived Delta 9 and Delta 8 distillate.
Organic Includes the word ‘organic.’ 8.8 43 All disposables are derived from USA Grown Hemp with high end organic terpenes.
Other Positive Effects 33.9 166
Promoting positive mood or feelings Includes claims that product use is associated with positive mood or feelings such as happiness and euphoria or associated with avoiding negative mood such as feeling down. 24.5 120 2 grams of delta-8 THC packed into a convenient 510 thread cartridge to deliver elevated happiness.
Relaxation/tension reduction Includes claims that product use is associated with relaxation or tension reduction and may include terms such as relaxed, calm, or chill. 19.6 96 User feedback describes effects of these disposable vapes as relaxing and perfect for unwinding after a long day.
Focus/creativity Includes claims that product use will result in better focus or concentration, alertness, creativity, awareness, etc. 5.3 26 Elevate your senses, unlock your creativity, and embrace the possibilities with these 2-grams disposables.
Health effects Includes claims that product use is associated with physical health benefits (e.g., pain, cancer), mental health benefits (e.g., stress, anxiety), general therapeutic health benefits, or sleep benefits. 4.1 20 Dealing with feelings of anxiety or physical discomfort may appear more manageable too.
Socialization effects Includes claims that product use may help with friendship, familiarity, romance, and closeness with others. 2.2 11 Perfect for daytime use, this all-in-one vape will obliterate creative roadblocks and is great for social gatherings thanks to its talkative effects.
1

The codes represent distinct product marketing features (e.g., product design), which are categorized under broader thematic categories (e.g., vape product design and use).

Data Analysis

Descriptive statistics (percent, mean, and standard deviation [SD]) for product attributes and marketing features were generated using Stata v.18.

RESULTS

Product Attributes

The 490 DICVPs (29.2% cartridge and 70.8% disposable) were from 95 unique brands (Table 2). The 10 most common brands were Delta Extrax (6.1%), Cake (5.9%), Looper (4.5%), Honeyroot (4.1%), Mellow Fellow (3.9%), Binoid (3.9%), TRE House (3.3%), Modus/Medusa (3.1%), Exhale (2.9%), and URB (2.9%).

Table 2.

Brands (n=95) of derived intoxicating cannabis vape products (n=490)

Derived intoxicating cannabis vape Products
Brand % n
Delta Extrax 6.1 30
Cake 5.9 29
Looper 4.5 22
Honeyroot 4.1 20
Binoid 3.9 19
Mellow Fellow 3.9 19
TRE House 3.3 16
Modus/Medusa 3.1 15
Exhale 2.9 14
URB 2.9 14
Purlyf 2.7 13
Flying Monkey 2.5 12
Kalibloom 2.5 12
ELYXR 2.2 11
Pacha 2.2 11
HiXotic 2.0 10
ZAZA 1.8 9
Ghost 1.6 8
Torch 1.6 8
Maui Labs 1.4 7
Trippy Sugar 1.4 7
ASTRO EIGHT 1.2 6
Dimo 1.2 6
Geek’d 1.2 6
Hidden Hills 1.2 6
Kik 1.2 6
Wild Orchard 1.2 6
Exodus 1.0 5
Happi 1.0 5
Ocho Extracts 1.0 5
Space Gods 1.0 5
D8Co. 0.8 4
Frozen Fields 0.8 4
Koi 0.8 4
Packwoods 0.8 4
Sugar 0.8 4
Zombi 0.8 4
Baked 0.6 3
Cali Reserve 0.6 3
ELF THC 0.6 3
Fume 0.6 3
Galaxy Treats 0.6 3
Ript 0.6 3
STIIIZY 0.6 3
STNR 0.6 3
Treetop 0.6 3
3Chi 0.4 2
Blazed 0.4 2
Canna River 0.4 2
Chapo Extrax 0.4 2
Crooked Creations 0.4 2
Delta Man 0.4 2
Dozo 0.4 2
Esco Bars 0.4 2
Goo’d 0.4 2
HIGH 0.4 2
Half Bak’d 0.4 2
Hazy Extrax 0.4 2
Juicy Kush 0.4 2
Just 0.4 2
Kream 0.4 2
Kush Burst 0.4 2
LITTO 0.4 2
Punch Labs 0.4 2
STILO 0.4 2
Slap Hemp 0.4 2
Space Monkey 0.4 2
Stoney 0.4 2
Strange Clouds 0.4 2
Tiny Dancer 0.4 2
Trip Drip 0.4 2
Two Hawk 0.4 2
Tyson 0.4 2
Wonderbrett 0.4 2
10X 0.2 1
8THS 0.2 1
Ace bar 0.2 1
Alibi 0.2 1
Artisan 0.2 1
Bad Days 0.2 1
Cali Extrax 0.2 1
Carats 0.2 1
Delta Munchies 0.2 1
Eighty Six 0.2 1
Fresh 0.2 1
High Nightcap 0.2 1
High Times 0.2 1
Hyper 0.2 1
Kush Kolectiv 0.2 1
Kynn 0.2 1
Moon Wlkr 0.2 1
Pax Era 0.2 1
Puff 0.2 1
Space Walker 0.2 1
Wavy 0.2 1

There were 26 different intoxicating cannabis compounds contained within these 490 DICVPs (Table 3). The most common compound was Delta-8 THC (67.8%), followed by THC-P (39.0%), HHC (20.2%), Delta-10 THC (16.3%), THC-A (13.9%), Delta-9 THC (12.0%), THC-H (11.2%), THC-B (10.2%), THC-JD (9.0%), and THC-X (7.1%). Although rare, a small percentage of DICVPs (3.1%) contained THC-O, a cannabinoid associated with pulmonary toxicity (28). Most of the products (62.9%) were blends, containing two or more intoxicating cannabinoids. The average number of intoxicating cannabinoids in each DICVP was 2.4 (range 1 to 8, SD = 1.5).

Table 3.

Types of cannabinoids (n=26) in derived intoxicating cannabis vape products (n=490)

Derived intoxicating cannabis vape products
Cannabinoid type % n
Delta-8 THC 67.8 332
THC-P 39.0 191
HHC 20.2 99
Delta-10 THC 16.3 80
THC-A 13.9 68
Delta-9 THC 12.0 59
THC-H 11.2 55
THC-B 10.2 50
THC-JD 9.0 44
THC-X 7.1 35
HHC-P 6.5 32
Delta-11 THC 5.9 29
PHC 5.9 29
THC-O 3.1 15
THC-m 2.9 14
THC-V 2.7 13
Delta-6 THC 2.5 12
HHC-O 2.0 10
HXC 1.0 5
HXC-P 0.8 4
THC-PO 0.6 3
Delta-9O THC 0.4 2
HHC-R 0.4 2
THD 0.4 2
HCP 0.2 1
HXCO 0.2 1

Most DICVPs were offered in a pack size of one (94.9%), and few came in packs of two (4.5%) or three (0.6%). Retail prices for the DICVPs ranged from $7.99 to $69.95, with an average price of $24.22 (SD = $8.10). The average price was $22.2 for cartridges (SD = $9.9) and $26.5 for disposables (SD = $7.9).

Product Marketing Features

Table 1 presents the frequencies of product marketing features in the DICVP descriptions, along with definitions and examples.

Vape product design and use

The most common marketing feature was vape product design and use (99.0%), defined as characteristics or features of product design and any aspects related to the user vaping experience. This included product design (97.6%, e.g., product color, shape), vaping satisfaction (28.2%, e.g., “leaving you satisfied after each hit”), discreetness/convenience (28.0%, e.g., “discreet,” “easy to use,” “on the go”), and use instructions (12.2%, e.g., how to power up the product).

Regulation and compliance

Regulation and compliance, defined as warning statements or claims about the product being compliant with cannabis laws or regulations, appeared in 91.6% of the descriptions. Specifically, this included messages that the product was lab tested for additives and/or chemicals (62.5%, e.g., “tested by third-party labs, this product is free of impurities and toxins”), health warnings (51.2%, the California state warning about health effects from using cannabis products), the claim that the product was derived from hemp (45.3%, “made from USA grown hemp”), the 2018 Farm Bill (32.7%, “these cartridges are 2018 Farm Bill compliant, containing less than 0.3% delta-9 THC”), and non-Food and Drug Administration (FDA) approval statements (6.3%, “these statements have not been evaluated by the FDA”). All identified health warnings were from California Prop 65 and only specific to Delta-9 THC products.

Flavor and sensation

Flavor and sensation claims, defined as specific or general flavor or flavor sensation references describing the taste of the products, or claims that the product comes in multiple flavors, were noted in 79.6% of product descriptions. This included flavor variety (62.9%, e.g., claims that the product comes in a variety of flavors), fruit flavor (38.2%, e.g., claims that include terms like “fruity,” “strawberry,” “watermelon”), general flavor descriptions (30.2%, “big flavor,” “delicious”), other flavor (29.4%, claims that include terms to describe a flavor that does not fall under fruit flavor categories, e.g., “mint,” “cake,” “cookies”), and flavor sensations (28.2%, terms that describe the tastes, smells, and textures of a flavor, e.g., “sweet,” “spicy”). Many flavor claims with trademark names of desserts and snacks were also identified in the descriptions during coding, including “Fruity Pebbles,” “Gushers,” “Hubba Bubba,” “Thin Mint Cookies,” and “Double Bubble.”

Psychoactive effects

Psychoactive effects (43.3%) were defined as descriptors, claims, or instructions related to the psychoactive properties or effects of a product. Specifically, this included product potency descriptors (35.3%, keywords such as “powerful,” “potent,” and “strong”), psychoactive effects on the user (14.7%, e.g., feeling high, buzzed, or stoned), and user instructions on managing psychoactive effects (9.0%, e.g., the number of puffs that one should be starting with).

Product quality

Product quality claims (38.4%) highlighted the products’ ingredients or standards that may communicate low risks of harm to consumers. These claims commonly included the keywords “natural” (16.5%, e.g., “flavored with all-natural terpenes”), “quality” (12.5%, e.g., “the highest quality distillate available”), “purity” (10.6%, e.g., “highly potent”), “premium” (10.2%, e.g., “contains 3 grams of premium hemp-derived Delta-8 distillate”), and “organic” (8.8%, e.g., “has high-end organic terpenes”).

Other positive effects

Lastly, other effects from product use (33.9%) included content that promoted positive mood and feelings (24.5%, e.g., happiness, euphoria), relaxation and tension reduction (19.6%, e.g., relaxed, chill, calming effect), focus/creativity (5.3%, e.g., better focus, concentration, creativity), positive health effects (4.1%, physical health benefits [e.g., pain, cancer], mental health benefits [e.g., anxiety, depression, sleep benefits], and socialization effects (2.2%, e.g., closeness with others, improves friendships).

DISCUSSION

This is one of the first studies to systematically examine the product attributes and marketing features of a large sample of flavored DICVPs sold by online retailers with a high volume of web traffic. Similar to the overall DICP marketplace (2), the market of DICVPs is highly fragmented, with 95 brands and 490 products being marketed and sold on the two websites in our study sample. The most common brand, Delta Extrax, only comprised 6% of the products included in the study. It is also worth noting that more than 60% of the examined DICVPs contained Delta-8 THC, for which youth use prevalence and negative health consequences have increased in recent years. Additionally, previous research has found that most Delta-8 THC DICVPs sold by online cannabis vape shops in San Diego, CA, are flavored (43). The variety of types of intoxicating cannabinoids also signifies the diversity of the marketplace. Most DICVPs use a blend of cannabinoids (e.g., Delta-8 THC, Delta-10 THC; THC-A, THC-JD, THC-P; Delta-9 THC, THC-A, THC-P), but little is known about the health effects from using many of these compounds individually, let alone in various combinations, which may result in stronger effects than anticipated by users or other adverse health effects (44). This fragmented market, defined by small brands and diverse products, may increase challenges for regulatory and enforcement efforts and overwhelm and confuse consumers, potentially leading to product misuse or health risks.

The most frequently promoted marketing features were those describing overall vape product design and use that were not specific to cannabis products. This information mostly included appealing aspects of vape products, which highlighted the “fun, coolness, and high technology” aspects of the product, as well as the “satisfying vaping experience” and the “discreetness and convenience of vaping.” Viewing this information may prompt those who have used nicotine vapes to transition to (or co-use) cannabis/DICP vapes due to the shared vaping experience. There were also specific instructions for vape device use, which may increase the perceived ease of product use for young individuals who are new to vaping devices (45). Overall, viewing information about vaping experience and use instructions may reduce the perceived barriers to DICVP use, inviting new consumers to experiment with products.

A large proportion of marketing features related to regulation and compliance was also found, which described that the products were lab-tested for additives and chemicals, the health warnings, and the legality of the products under the 2018 Farm Bill. However, it may be challenging for consumers to interpret and verify the provided information, including whether these products were actually lab-tested and whether these labs are accredited or not, as the cannabis industry has increasingly falsified lab testing results (46). In addition, viewing information stating the products are lab-tested and legal under the Farm Bill may increase the perceived legality and safety of these products, which may promote use, especially among those in states where non-medical cannabis sales are illegal (6,47). Future studies should assess the accreditation status of lab tests to help validate the accuracy of lab testing claims for DICPs in today’s online retail landscape.

Warnings related to the health risks of cannabis use – all from California Prop 65 and specific to Delta-9 THC – were only found in the descriptions of products sold on Element Vape, likely because the online company is based in California. However, it is common for online retailers that sell or ship products nationwide to include Prop 65 warnings if there is a possibility their products could be sold in California, due to the law’s broad reach and the potential risk of litigation. Premium Delta-8 and CBD may be among other DICP online retailers that do not include health warnings in their marketing because of the unregulated DICP landscape. Although evidence has shown that cannabis health warnings, especially those with images and describing specific risks, increase notice, recall, and health knowledge (48); a recent study found that viewing a hypothetical warning specifically for Delta-8 THC cannabis edible and vape products increased youth’s perceived intoxication and harm of Delta-8 products (49). More research on the impact of Prop 65 warning labels and the health consequences of other intoxicating cannabinoids is needed to inform warning and preventive messaging.

Flavor and sensation claims, a commonly found marketing strategy in this study, may enhance consumer preferences and curiosity about using DICVPs. Extensive literature on nicotine vape product marketing has shown that flavor-related descriptors (especially fruit flavors), flavor choices, and flavor sensation-related claims are among the most appealing marketing features in their advertisements among young individuals, and that those features often generate an increased willingness to try the products shown in the advertisements (15,3537). This may be especially true given that artificial flavors from the e-cigarette industry are used for cannabis vapes (38). Many of the flavor and sensation claims in the descriptions convey youth-friendly tastes and aromas that may instigate product curiosity from this group. In addition, a series of trademarked names of popular desserts and snacks were used in these claims, possibly constituting trademark infringement. Such flavor names may make DICVPs more appealing to youth and lead them to perceive the products as food or candy rather than a potentially harmful substance. Although local regulations on traditional cannabis and DICPs have not started restricting product flavors, many jurisdictions prohibit traditional cannabis product marketing that targets minors (53). Studies are needed to examine whether and how DICVP marketing strategies with youth-appealing flavor and sensation claims may prompt product use.

Promoting psychoactive effects was also a commonly used marketing strategy for DICVPs. Such claims may increase consumers’ intentions to use these products, as achieving a “high” is a widely recognized motivation for cannabis use (54). Other purported positive effects identified—such as mood enhancement, improved socialization, and increased focus or creativity—align with well-established cannabis use expectancies in the literature (55,56). According to the means-end approach in advertising theory, marketing product features highlighting the functions and benefits of products, can shape motives and expectations related to product use, effectively driving interest in use (57). Finally, there was a small number of descriptions stating unfounded or misleading health effect claims (e.g., reducing stress and anxiety) to describe the positive benefits of DICVP use. To prevent deceptive advertising practices, ongoing monitoring of health-related claims for DICVPs – and DICPs overall – is needed (58).

There was also an extensive number of claims indicating product quality, including using descriptors of “natural,” “quality,” “purity,” “premium,” and “organic.” According to the evidence from tobacco marketing literature, some of these descriptors may reduce perceived harm and risks from product use and promote use intentions. This may also create the “health halo” effect, observed in tobacco and food industry marketing (64), where consumers may overestimate a product’s healthiness based on ingredient claims suggesting the quality or cleanness of the products. Research on how these marketing claims related to high product quality may affect risk perceptions of DICVP use is especially needed because the public has increasingly considered cannabis (and cannabis vape products) to be “healthy” and “harm-free” (65,66) — a belief that will become even more common as cannabis products become further normalized.

Strengths and Limitations

This study used product attributes and descriptions from highly visited online retail websites to gather key insights into the existing retail market environment for a large number of DICVPs. However, this study only collected data from two websites, making it unrepresentative of the broader retail market, including brick-and-mortar stores, and it did not examine consumer purchasing habits or product use patterns. Because of the rapidly evolving nature of the DICVP marketplace, continuous monitoring of product attributes and marketing features is needed. Furthermore, this analysis did not examine marketing features shown on product packages, which can also contain youth-appealing features such as cartoons and anime, fruit and candy images, and vibrant colors that may generate product use interest among young people. Lastly, all DICVPs included in our analysis are flavored. Although most DICVPs are flavored in the online retail market (43), unflavored products also exist (e.g., raw distillate) and therefore, the products in this analysis may be unrepresentative of the broader retail market.

CONCLUSIONS

This study provides a comprehensive analysis of the current online retail market for DICVPs, highlighting its variety of brands, intoxicating compounds, and marketing features that may appeal to younger or novice consumers. Such marketing features, such as those related to product design and flavor profile and sensation, may shape perceptions that the products are visually appealing, easy to use, and taste like fruit and candy. The rapid diversification of this market necessitates continuous monitoring, with future research needed to explore consumer purchasing patterns and use behaviors. Future research should also assess the need for regulatory measures, such as mandatory health warnings on DICP marketing materials. Such data are essential for guiding policy, public health practices, and further research efforts related to DICVP marketing. Future research examining how these marketing features may impact use behaviors can inform policymaking for reducing product youth appeal.

Funding source:

Dr. LoParco is supported by the National Institute on Drug Abuse (F32DA060612). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Footnotes

Disclosure: Dr. Kong has served as a paid expert consultant in litigation against the tobacco industry.

REFERENCES

  • 1.Abernethy A Hemp Production and the 2018 Farm Bill [Internet]. U.S. Food and Drug Administration; 2019. Jul. Available from: https://www.agriculture.senate.gov/imo/media/doc/Testimony_Abernethy%2007.25.19.pdf [Google Scholar]
  • 2.Rossheim ME, Tillett KK, Vasilev V, LoParco CR, Berg CJ, Trangenstein PJ, et al. Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023. Cannabis and Cannabinoid Research. 2024. Jan 19;can.2023.0266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: a scoping review and commentary. Addiction. 2023. Jun;118(6):1011–28. [DOI] [PubMed] [Google Scholar]
  • 4.Rossheim ME, LoParco CR, Walker A, Livingston MD, Trangenstein PJ, Olsson S, et al. Delta-8 THC Retail Availability, Price, and Minimum Purchase Age. Cannabis and Cannabinoid Research. 2024. Feb 1;9(1):363–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Babalonis S, Raup-Konsavage WM, Akpunonu PD, Balla A, Vrana KE. Δ8-THC: legal status, widespread availability, and safety concerns. Cannabis and Cannabinoid Research. 2021;6(5):362–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rossheim ME, LoParco CR, Tillett KK, Treffers RD, Livingston MD, Berg CJ. Intoxicating cannabis products in vape shops: United States, 2023. American journal of preventive medicine. 2024;67(5):776–84. [DOI] [PubMed] [Google Scholar]
  • 7.LoParco CR, Rossheim ME, Cui Y, McCready DM, Romm KF, Wang Y, et al. Derived psychoactive cannabis product perceptions and use among a sample of US young adults. Addictive behaviors. 2025;160:108180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.LoParco CR, Henry D, Prater Z, Bone C, Rossheim ME, Berg CJ. “Non-Flavor” Flavors: What Are the Implications of Derived Psychoactive Cannabis Product Marketing? J Stud Alcohol Drugs. 2024. Sep;85(5):756–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.LoParco CR, Bone C, Garg A, Berg CJ, Rossheim ME. Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products. Journal of Psychoactive Drugs. 2025. Mar 25;1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rossheim ME, LoParco CR, Berg CJ, Tillett KK, Trangenstein PJ, Henry D, et al. Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023. Drug and alcohol dependence. 2024;256:111119. [DOI] [PubMed] [Google Scholar]
  • 11.National Institute on Drug Abuse. Reported use of most drugs among adolescents remained low in 2024. National Institute on Drug Abuse (NIDA) [Internet]. 2024. [cited 2025 Jul 17]. Available from: https://nida.nih.gov/news-events/news-releases/2024/12/reported-use-of-most-drugs-among-adolescents-remained-low-in-2024 [Google Scholar]
  • 12.Rossheim ME, Loparco CR, Henry D, Trangenstein PJ, Walters ST. Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products? J Stud Alcohol Drugs. 2023. May;84(3):357–60. [DOI] [PubMed] [Google Scholar]
  • 13.National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017. (The National Academies Collection: Reports funded by National Institutes of Health). [Google Scholar]
  • 14.LoParco CR, Tillett KK, Chen-Sankey J, Berg CJ, Rossheim ME. Public health considerations about tetrahydrocannabinol-infused beverages. Addiction. 2024. Sep 26;add.16676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Luc MH, Tsang SW, Thrul J, Kennedy RD, Moran MB. Content analysis of online product descriptions from cannabis retailers in six US states. International Journal of Drug Policy. 2020;75:102593. [DOI] [PubMed] [Google Scholar]
  • 16.Rossheim ME, Tillett KK, LoParco CR, Livingston MD, Soule EK, Berg CJ. Pediatric Cannabis Poisonings, United States Hospital Emergency Departments, 2018–2023. Health Behavior Research. 2025;8(3):2. [Google Scholar]
  • 17.Meehan-Atrash J, Rahman I. Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals. Chem Res Toxicol 2022. Jan 17;35(1):73–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Smith GA, Burgess A, Badeti J, Rine NI, Gaw CE, Middelberg LK, et al. Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy. J Med Toxicol 2024. Oct;20(4):389–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hinckley JD, Hopfer C. Marijuana legalization in Colorado: increasing potency, changing risk perceptions, and emerging public health concerns for youth. Adolescent psychiatry (Hilversum, Netherlands). 2021;11(2):95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA psychiatry. 2016;73(3):292–7. [DOI] [PubMed] [Google Scholar]
  • 21.Nali MC, Yang JS, Li Z, Larsen MZ, Mackey TK. Cannabis-derived product types, flavors, and compound types from an e-commerce website. JAMA Network Open. 2024;7(10):e2440376–e2440376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen-Sankey J, Jeong M, Wackowski OA, Unger JB, Niederdeppe J, Bernat E, et al. Noticing People, Discounts, and Non-Tobacco Flavors in E-cigarette Ads May Increase E-cigarette Product Appeal among Non-Tobacco-Using Young Adults. Published online first. Tobacco Control. 2022. Jun 7; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chen-Sankey JC, Kong G, Choi K. Perceived ease of flavored e-cigarette use and e-cigarette use progression among youth never tobacco users. PloS one. 2019;14(2). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen JC, Green K, Fryer C, Borzekowski D. Perceptions about e-cigarette flavors: a qualitative investigation of young adult cigarette smokers who use e-cigarettes. Addiction Research & Theory. 2019;27(5):420–8. [Google Scholar]
  • 25.Hasin DS, Borodovsky J, Shmulewitz D, Walsh C, Livne O, Struble CA, et al. Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws. Drug and Alcohol Dependence. 2021. Dec 1;229:109159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Spindle TR, Cone EJ, Schlienz NJ, Mitchell JM, Bigelow GE, Flegel R, et al. Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: A crossover trial. JAMA Netw Open. 2018. Nov 30;1(7):e184841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Adapa S, Gayam V, Konala VM, Annangi S, Raju MP, Bezwada V, et al. Cannabis Vaping–Induced Acute Pulmonary Toxicity: Case Series and Review of Literature. Journal of Investigative Medicine High Impact Case Reports [Internet]. 2020. Jan [cited 2025 Jul 17];8. Available from: https://journals.sagepub.com/doi/10.1177/2324709620947267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Benowitz NL, Havel C, Jacob P, O’Shea DF, Wu D, Fowles J. Vaping THC-O Acetate: Potential for Another EVALI Epidemic. J Med Toxicol 2023. Jan;19(1):37–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Spindle TR, Martin EL, Grabenauer M, Woodward T, Milburn MA, Vandrey R. Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis. J Psychopharmacol 2021. Jul;35(7):786–803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Barrus DG, Capogrossi KL, Cates SC, Gourdet CK, Peiper NC, Novak SP, et al. Tasty THC: promises and challenges of cannabis edibles. Methods report (RTI Press). 2016;2016:10–3768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Trangenstein PJ, Whitehill JM, Jenkins MC, Jernigan DH, Moreno MA. Active cannabis marketing and adolescent past-year cannabis use. Drug and alcohol dependence. 2019;204:107548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Vassey J, Cho J, Vogel EA, Iyer T, Chen-Sankey J, Unger JB. E-Cigarette and Cannabis Social Media Posts and Adolescent Substance Use. JAMA Network Open. 2025;8(6):e2517611–e2517611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lee J, Krishnan-Sarin S, Kong G. Social media use and cannabis vaping initiation among US youth. Drug and alcohol dependence. 2023;249:109949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Shi Y, Cao Y, Shang C, Pacula RL. The impacts of potency, warning messages, and price on preferences for Cannabis flower products. International Journal of Drug Policy. 2019;74:1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Zhu B, Guo H, Cao Y, An R, Shi Y. Perceived importance of factors in cannabis purchase decisions: a best-worst scaling experiment. International Journal of Drug Policy. 2021;91:102793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chen-Sankey J, La Capria K, Meng S, Mazzeo R, Vijayakumar N, Padon AA, et al. Product Features Used to Promote Top-selling Cannabis Vape Products in An Online Retail Environment. Addiction Research & Theory. 2025; [Google Scholar]
  • 37.LoParco CR, Tillett KK, Berg CJ, Rossheim ME. Online retail of derived psychoactive cannabis products: age and shipping restrictions. Journal of Adolescent Health [Internet]. 2024. [cited 2024 Dec 9]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Egan KL, Villani S, Soule EK. Absence of age verification for online purchases of Cannabidiol and Delta-8: Implications for youth access. Journal of Adolescent Health. 2023;73(1):195–7. [DOI] [PubMed] [Google Scholar]
  • 39.Rossheim ME, Tillett KK, Vasilev V, LoParco CR, Berg CJ, Trangenstein PJ, et al. Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023. Cannabis and Cannabinoid Research. 2024. Jan 19;can.2023.0266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Cavazos-Rehg PA, Krauss MJ, Cahn E, Lee KE, Ferguson E, Rajbhandari B, et al. Marijuana promotion online: An investigation of dispensary practices. Prevention Science. 2019;20:280–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kowitt SD, Yockey RA, Lee JG, Jarman KL, Gourdet CK, Ranney LM. The impact of cannabis packaging characteristics on perceptions and intentions. American journal of preventive medicine. 2022;63(5):751–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Krippendorff K Measuring the reliability of qualitative text analysis data. Quality and quantity. 2004;38:787–800. [Google Scholar]
  • 43.Satybaldiyeva N, Harati R, Mejorado T, Morales N, Benitez G, Ellis SE, et al. Derived cannabinoid product availability among online vape shops. Preventive Medicine Reports. 2024;48:102910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Harlow AF, Leventhal AM, Barrington-Trimis JL. Closing the loophole on hemp-derived cannabis products: a public health priority. JAMA 2022;328(20):2007–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Farrelly MC, Duke JC, Crankshaw EC, Eggers ME, Lee YO, Nonnemaker JM, et al. A randomized trial of the effect of e-cigarette TV advertisements on intentions to use e-cigarettes. American journal of preventive medicine. 2015;49(5):686–93. [DOI] [PubMed] [Google Scholar]
  • 46.Chemical & Engineering News [Internet]. [cited 2025 Jan 17]. Shopping around for favorable cannabis testing labs. Available from: https://cen.acs.org/biological-chemistry/natural-products/Shopping-around-favorable-cannabis-testing/102/i28 [Google Scholar]
  • 47.Livingston MD, Walker A, Cannell MB, Rossheim ME. Popularity of Delta-8 THC on the Internet Across US States, 2021. Am J Public Health. 2022. Feb;112(2):296–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Massey ZB, Hammond D, Froeliger B. A systematic review of cannabis health warning research. Preventive medicine reports. 2024;37:102573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Harlow AF, Leventhal AM, Barrington-Trimis JL. Impact of Delta-8-THC warning labels on perceived intoxication, harm, and susceptibility among adolescents. International Journal of Drug Policy. 2025;139:104781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.La Capria K, Uriarte C, Elhabashy M, Menkevich M, Maxton O, Awadalla J, et al. Exploring the Influence of E-cigarette Ad Features on Perceived Product Appeal and Use Interest Among Young Adults of Varying Tobacco-Use Behaviors. Nicotine Tob Res 2023;ntad150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chen-Sankey J, Weiger C, La Capria K. Using Eye Tracking to Examine Young Adults’ Visual Attention to E-cigarette Advertising Features and Associated Positive E-cigarette Perceptions. Annals of Behavioral Medicine. 2024; 58(6): 445–456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Chen-Sankey J, Weiger C, La Capria K, Vassey J, Jeong M, Phan L, et al. Young Adults’ Visual Attention to Features of Social Media Marketing for Disposable E-cigarettes and Associated Perceptions. Addiction; 120 (3), 439–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.State-Regulation-of-Adult-Use-Cannabis-Advertising.pdf [Internet]. [cited 2023 Dec 13]. Available from: https://www.networkforphl.org/wp-content/uploads/2022/11/State-Regulation-of-Adult-Use-Cannabis-Advertising.pdf [Google Scholar]
  • 54.Bray BC, Berglund PA, Evans-Polce RJ, Patrick ME. A Latent Transition Analysis of Self-Reported Reasons for Marijuana Use During Young Adulthood. Eval Health Prof 2021. Mar;44(1):9–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lee CM, Neighbors C, Woods BA. Marijuana motives: young adults’ reasons for using marijuana. Addict Behav 2007. Jul;32(7):1384–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Buckner JD, Ecker AH, Welch KD. Psychometric properties of a valuations scale for the Marijuana Effect Expectancies Questionnaire. Addict Behav 2013. Mar;38(3):1629–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Reynolds TJ, Olson JC. Understanding consumer decision making: The means-end approach to marketing and advertising strategy [Internet]. Psychology Press; 2001. [cited 2024 Apr 9]. [Google Scholar]
  • 58.Federal Trade Commission [Internet]. 2021. [cited 2024 Dec 18]. FTC and CBD: Latest case challenges unproven health claims. Available from: https://www.ftc.gov/business-guidance/blog/2021/05/ftc-cbd-latest-case-challenges-unproven-health-claims [Google Scholar]
  • 59.Moran MB, Heley K, Czaplicki L, Weiger C, Strong D, Pierce J. Tobacco Advertising Features That May Contribute to Product Appeal Among US Adolescents and Young Adults. Nicotine Tob Res 2021. Aug 4;23(8):1373–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Iles IA, Pearson JL, Lindblom E, Moran MB. “Tobacco and Water”: Testing the Health Halo Effect of Natural American Spirit Cigarette Ads and Its Relationship with Perceived Absolute Harm and Use Intentions. Health Commun 2020. Jan 10;36(7):804–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Berg CJ, Duan Z, Wang Y, Thrasher JF, Abroms LC, Khayat A, et al. Impact of different health warning label and reduced exposure messages in IQOS ads on perceptions among US and Israeli adults. Prev Med Rep 2023. Apr 15;33:102209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Duan Z, Levine H, Bar-Zeev Y, Cui Y, LoParco CR, Wang Y, et al. Health warning labels on heated tobacco products and their impact on use intentions and risk perceptions: a cross-sectional study of adult tobacco users in the US and Israel. Isr J Health Policy Res 2023. Nov 13;12(1):33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chen-Sankey J, Ganz O, Seidenberg A, Choi K. Effect of a “tobacco-free nicotine” claim on intentions and perceptions of Puff Bar e-cigarette use among non-tobacco-using young adults. Tobacco control. 2023;32(4):501–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Williams P Consumer Understanding and Use of Health Claims for Foods. Nutrition Reviews. 2005. Jul;63(7):256–64. [DOI] [PubMed] [Google Scholar]
  • 65.Levy NS, Mauro PM, Mauro CM, Segura LE, Martins SS. Joint perceptions of the risk and availability of cannabis in the United States, 2002–2018. Drug and alcohol dependence. 2021. Sep;226:108873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Pacek LR, Mauro PM, Martins SS. Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug and alcohol dependence. 2015. Apr;149:232–44. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES